UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service

LOS ANGELES, June 1 (Korea Bizwire) — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announced today that its EyeArt® system has been confirmed to have “sufficient high quality evidence” as “safe and cost-effective,” and is the [...]